Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.
Monica B ArrudaLídia T BoullosaCynthia C CardosoCarolina M da CostaCarlos Rb AlvesShirlene Ts de LimaHelena T KaminskiAgdemir W AleixoAna Op EspositoAna Ms CavalcantiMaristela RiedelJosé C Couto-FernandezSelma B FerreiraIvi Cm de OliveiraLoreci E PortalHilda Hc WolfSandra B FernandesMaria I de M C PardiniManoel Vc FeiteiroFernanda M TolentinoRicardo S DiazGiselle Isl LopesRoberta Bl FranciscoNazle Mc VérasAna F PiresMiriam FranchiniFábio MesquitaAmilcar Tanurinull nullPublished in: Journal of the International AIDS Society (2019)
To the best of our knowledge, this is the first TDR study conducted in Brazil with nationwide representative sampling. The TDR prevalence revealed a moderate rate in the five Brazilian geographical regions, although some cities presented higher TDR prevalence rates, reaching 14% in São Paulo, for example. These results further illustrate the importance of surveillance studies for designing future strategies in primary antiretroviral therapy, aiming to mitigate TDR, as well as for predicting future trends in other regions of the globe where mass antiretroviral (ARV) treatment was implemented.